On behalf of Health Minister Ginette Petitpas Taylor (Moncton–Riverview–Dieppe, N.B.), Liberal MP Colin Fraser (West Nova, N.S.) announced an investment of $967,000 over four years to the Tri-County Women’s Centre Society in Nova Scotia under Health Canada’s Substance Use and Addictions Program. This funding will support the society in raising awareness of the health effects of cannabis and … Read more
Liberal MP Wayne Long (Saint John-Rothesay, N.B.) announced an investment of $1.14 million over three years to the John Howard Society of New Brunswick under Health Canada’s Substance Use and Addictions Program. This funding will support the John Howard Society of New Brunswick in raising awareness of the health effects of cannabis and the dangers of drug-impaired … Read more
The Cannabis Act will come into force on October 17, 2018. The Government of Canada has committed to fully recovering the costs of regulating the cannabis industry. Health Canada has modified the design of the annual regulatory fee to use previous year’s revenue to calculate the fee rather than forecasted revenue. These measures will help … Read more
Health Canada reviewed the drug edaravone, a new treatment for Amyotrophic Lateral Sclerosis, through its priority review process. Health Canada also worked with the manufacturer and the ALS network to make the drug available through the Department’s Special Access Programme. Health Canada will continue to work with the manufacturer to facilitate access to edaravone until the authorized drug is … Read more
The governments of Canada and British Columbia have signed a bilateral agreement outlining how the province plans to invest its share of targeted federal funding. The agreement represents a shift in how the federal and provincial governments work together to advance shared health priorities. Through this agreement, B.C. will invest approximately $394 million in targeted federal … Read more
Dr. Theresa Tam and Dr. Robert Strang, co-chairs of the Special Advisory Committee on the Epidemic of Opioid Overdoses Regarding issued the following statement: “Today, on behalf of the federal, provincial and territorial Special Advisory Committee on the Epidemic of Opioid Overdoses, the Public Health Agency of Canada is releasing data on apparent opioid-related deaths in Canada for … Read more
Health Minister Ginette Petitpas Taylor (Moncton–Riverview–Dieppe, N.B.) announced that Health Canada’s ban on partially hydrogenated oils (PHOs)—the largest source of industrially produced trans fats in foods—has come into effect. It is now illegal for manufacturers to add PHOs to foods sold in Canada. This includes Canadian and imported foods, as well as those prepared in all … Read more
Health Canada is advising Canadians that a second impurity, called N-nitrosodiethylamine (NDEA) has been found in valsartan manufactured by Zhejiang Huahai Pharmaceuticals in China. All drugs containing valsartan manufactured by Zhejiang Huahai Pharmaceuticals have already been recalled in Canada after the first impurity, N-nitrosodimethylamine (NDMA), was identified earlier this summer. Both NDEA and NDMA are classified … Read more
On September 6, 2018, Health Minister Ginette Petitpas Taylor (Moncton–Riverview–Dieppe, N.B.) and Judy Darcy, Minister of Mental Health and Addictions in B.C., announced a bilateral agreement signed under the Government of Canada’s new Emergency Treatment Fund. This agreement recognizes the investment of more than $71.7 million— $33.98 million from the Government of Canada, in addition to the province … Read more
Health Minister Ginette Petitpas Taylor (Moncton–Riverview–Dieppe, N.B.) launched a two-day Opioid Symposium, bringing together close to 200 participants to discuss how to reverse the trend of the national overdose epidemic. Over the course of two days, participants will address topics such as stigma, treatment, harm reduction and enforcement and how the crisis impacts different communities across the … Read more
